Di G - Search Results

1

Time-varying pattern of recurrence risk for Chinese breast cancer patients.

Yin W, Di G, Zhou L, Lu J, Liu G, Wu J, Shen K, Han Q, Shen Z, Shao Z. Yin W, et al. Among authors: di g. Breast Cancer Res Treat. 2009 Apr;114(3):527-35. doi: 10.1007/s10549-008-0022-5. Epub 2008 Apr 19. Breast Cancer Res Treat. 2009. PMID: 18425576

2

Clinical significance of aromatase protein expression in axillary node negative breast cancer.

Lu J, Li H, Cao D, Di G, Wu J, Sheng K, Han Q, Shen Z, Shao Z. Lu J, et al. Among authors: di g. J Cancer Res Clin Oncol. 2007 Jun;133(6):401-9. doi: 10.1007/s00432-006-0186-5. Epub 2007 Jan 12. J Cancer Res Clin Oncol. 2007. PMID: 17219197

3

Site-specific relapse pattern of the triple negative tumors in Chinese breast cancer patients.

Lin Y, Yin W, Yan T, Zhou L, Di G, Wu J, Shen Z, Shao Z, Lu J. Lin Y, et al. Among authors: di g. BMC Cancer. 2009 Sep 24;9:342. doi: 10.1186/1471-2407-9-342. BMC Cancer. 2009. PMID: 19778431 Free PMC article.

4

The prognostic role of cancer stem cells in breast cancer: a meta-analysis of published literatures.

Zhou L, Jiang Y, Yan T, Di G, Shen Z, Shao Z, Lu J. Zhou L, et al. Among authors: di g. Breast Cancer Res Treat. 2010 Aug;122(3):795-801. doi: 10.1007/s10549-010-0999-4. Epub 2010 Jun 23. Breast Cancer Res Treat. 2010. PMID: 20571867

5

Prognostic and predictive value of TFF1 for adjuvant endocrine therapy in Chinese women with early ER positive breast cancer: comparing aromatase inhibitors with tamoxifen.

Zhou L, Yan T, Jiang Y, Di G, Shen Z, Shao Z, Lu J. Zhou L, et al. Among authors: di g. Breast. 2011 Feb;20(1):15-20. doi: 10.1016/j.breast.2010.06.002. Epub 2010 Jul 8. Breast. 2011. PMID: 20619646 Free article.

6

The role of topoisomerase IIα in predicting sensitivity to anthracyclines in breast cancer patients: a meta-analysis of published literatures.

Du Y, Zhou Q, Yin W, Zhou L, Di G, Shen Z, Shao Z, Lu J. Du Y, et al. Among authors: di g. Breast Cancer Res Treat. 2011 Oct;129(3):839-48. doi: 10.1007/s10549-011-1694-9. Epub 2011 Aug 2. Breast Cancer Res Treat. 2011. PMID: 21809115

7

Pathological complete response as a surrogate for relapse-free survival in patients with triple negative breast cancer after neoadjuvant chemotherapy.

Li J, Chen S, Chen C, Di G, Liu G, Wu J, Shao Z. Li J, et al. Among authors: di g. Oncotarget. 2017 Mar 14;8(11):18399-18408. doi: 10.18632/oncotarget.9369. Oncotarget. 2017. PMID: 27191991 Free PMC article.

8

Quality of Life and Psychological State in Chinese Breast Cancer Patients Who Received BRCA1/2 Genetic Testing.

Qiu J, Guan J, Yang X, Wu J, Liu G, Di G, Chen C, Hou Y, Han Q, Shen Z, Shao Z, Hu Z. Qiu J, et al. Among authors: di g. PLoS One. 2016 Jul 18;11(7):e0158531. doi: 10.1371/journal.pone.0158531. eCollection 2016. PLoS One. 2016. PMID: 27428375 Free PMC article.

9

The role of mammographic calcification in the neoadjuvant therapy of breast cancer imaging evaluation.

Li JJ, Chen C, Gu Y, Di G, Wu J, Liu G, Shao Z. Li JJ, et al. Among authors: di g. PLoS One. 2014 Feb 11;9(2):e88853. doi: 10.1371/journal.pone.0088853. eCollection 2014. PLoS One. 2014. PMID: 24523942 Free PMC article. Clinical Trial.

10

Cisplatin and gemcitabine as the first line therapy in metastatic triple negative breast cancer.

Zhang J, Wang Z, Hu X, Wang B, Wang L, Yang W, Liu Y, Liu G, Di G, Hu Z, Wu J, Shao Z. Zhang J, et al. Among authors: di g. Int J Cancer. 2015 Jan 1;136(1):204-11. doi: 10.1002/ijc.28966. Epub 2014 May 23. Int J Cancer. 2015. PMID: 24824628 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

364 results

Search Page

Filters